BlackRock, Inc. 13D and 13G filings for Meridian Bioscience, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-01-26 08:52 am Unchanged | 2022-12-31 | 13G | Meridian Bioscience, Inc. VIVO | BlackRock Inc. BLK | 7,557,772 17.200% | 0 (Unchanged) | Filing |
| 2023-01-20 5:17 pm Purchase | 2022-12-31 | 13G | Meridian Bioscience, Inc. VIVO | BlackRock Inc. BLK | 7,557,772 17.200% | 151,847 (+2.05%) | Filing |
| 2022-01-27 11:00 am Unchanged | 2021-12-31 | 13G | Meridian Bioscience, Inc. VIVO | BlackRock Inc. BLK | 7,405,925 17.000% | 0 (Unchanged) | Filing |
| 2022-01-25 3:03 pm Purchase | 2021-12-31 | 13G | Meridian Bioscience, Inc. VIVO | BlackRock Inc. BLK | 7,405,925 17.000% | 558,178 (+8.15%) | Filing |
| 2021-01-25 4:50 pm Sale | 2020-12-31 | 13G | Meridian Bioscience, Inc. VIVO | BlackRock Inc. BLK | 6,847,747 15.900% | -58,462 (-0.85%) | Filing |